Enanta Pharmaceuticals (NASDAQ:ENTA) Downgraded by Wall Street Zen to “Sell”
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday. Separately, JMP Securities upped their price objective on shares of Enanta Pharmaceuticals from $23.00 to $24.00 and gave the company a “market outperform” rating in […]
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a report released on Saturday. Separately, JMP Securities upped their price objective on shares of Enanta Pharmaceuticals from $23.00 to $24.00 and gave the company a “market outperform” rating in […]
